Safety and tolerability of NVA237, a once-daily long-acting muscarinic antagonist, in COPD patients

  1. Vogelmeier, C.
  2. Verkindre, C.
  3. Cheung, D.
  4. Galdiz, J.B.
  5. Güçlü, S.Z.
  6. Spangenthal, S.
  7. Overend, T.
  8. Henley, M.
  9. Mizutani, G.
  10. Zeldin, R.K.
Revue:
Pulmonary Pharmacology and Therapeutics

ISSN: 1094-5539 1522-9629

Année de publication: 2010

Volumen: 23

Número: 5

Pages: 438-444

Type: Article

DOI: 10.1016/J.PUPT.2010.04.005 GOOGLE SCHOLAR

Objectifs de Développement Durable